← Back to Clinical Trials
Recruiting NCT07801807

NCT07801807 Short-Axis Versus Long-Axis Ultrasound-Guided Radial Artery Cannulation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07801807
Status Recruiting
Phase —
Sponsor Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Condition Radial Artery Cannulation
Study Type INTERVENTIONAL
Enrollment 144 participants
Start Date 2026-08-25
Primary Completion 2026-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Short-Axis/Out-of-Plane Radial Artery CannulationLong-Axis/In-Plane Radial Artery Cannulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 144 participants in total. It began in 2026-08-25 with a primary completion date of 2026-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled study aims to compare short-axis/out-of-plane and long-axis/in-plane ultrasound-guided techniques for radial artery cannulation in adult patients undergoing elective surgery. The study will also investigate whether the depth of the radial artery from the skin is associated with cannulation success and may help guide the selection of the ultrasound-guided cannulation technique. Participants will be randomly assigned to either the short-axis/out-of-plane group or the long-axis/in-plane group. Radial artery depth will be measured using ultrasound before cannulation. The two techniques will be compared in terms of cannulation success, including first-attempt success, number of punctures and needle redirections, time to successful cannulation, failed cannulation, and procedure-related complications.

Eligibility Criteria

nclusion Criteria: Age 18 years or older Patients with an indication for radial artery cannulation for invasive arterial monitoring Undergoing a surgical or interventional procedure Radial artery suitable for visualization by ultrasound Provision of written informed consent Exclusion Criteria: Age younger than 18 years Infection, burn, scar, or skin lesion at the planned cannulation site Previous vascular surgery involving the study extremity Advanced peripheral arterial disease or radial artery occlusion Inadequate collateral circulation as assessed by the Allen test or ultrasound Severe coagulopathy Presence of an arteriovenous fistula in the study extremity Severe hemodynamic instability Multiple previous failed radial artery cannulation attempts in the same extremity Pregnancy Allergy to ultrasound gel Refusal to participate in the study

Contact & Investigator

Central Contact

Fikret Salik, MD

✉ fikretsalik@gmail.com

📞 +90 507 621 4125

Principal Investigator

Fikret Salik, MD

PRINCIPAL INVESTIGATOR

Dicle University Faculty of Medicine

Frequently Asked Questions

Who can join the NCT07801807 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Radial Artery Cannulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07801807 currently recruiting?

Yes, NCT07801807 is actively recruiting participants. Contact the research team at fikretsalik@gmail.com for enrollment information.

Where is the NCT07801807 trial being conducted?

This trial is being conducted at Diyarbakır, Turkey (Türkiye), Diyarbakır, Turkey (Türkiye).

Who is sponsoring the NCT07801807 clinical trial?

NCT07801807 is sponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital. The principal investigator is Fikret Salik, MD at Dicle University Faculty of Medicine. The trial plans to enroll 144 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology